IPHS - Innophos Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
758,544
801,842
722,024
725,345
789,147
Cost of Revenue
623,525
658,451
572,995
574,953
645,818
Gross Profit
135,019
143,391
149,029
150,392
143,329
Operating Expenses
Research Development
4,838
5,076
3,733
3,739
4,502
Selling General and Administrative
74,058
81,101
82,229
67,555
87,304
Total Operating Expenses
78,896
86,177
85,962
71,294
91,806
Operating Income or Loss
56,123
57,214
63,067
79,098
51,523
Interest Expense
15,261
13,168
6,703
7,042
6,968
Total Other Income/Expenses Net
402
-459
578
-1,111
-3,882
Income Before Tax
40,952
43,232
56,637
70,318
40,123
Income Tax Expense
19,586
7,161
34,192
22,347
13,777
Income from Continuing Operations
21,366
36,071
22,445
47,971
26,346
Net Income
21,366
36,071
22,445
47,971
26,346
Net Income available to common shareholders
21,275
35,940
22,369
47,683
26,274
Reported EPS
Basic
-
1.84
1.15
2.47
1.31
Diluted
-
1.82
1.13
2.44
1.29
Weighted average shares outstanding
Basic
-
19,613
19,538
19,455
20,032
Diluted
-
19,760
19,733
19,581
20,323
EBITDA
-
101,331
103,744
114,839
85,626